• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMONIA AT CAMP WHEELER. Wheeler 营的肺炎预防接种结果。
J Exp Med. 1919 May 1;29(5):457-83. doi: 10.1084/jem.29.5.457.
2
RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.预防接种肺炎球菌疫苗对 12519 名男性的效果。
J Exp Med. 1918 Jul 1;28(1):19-41. doi: 10.1084/jem.28.1.19.
3
STUDIES ON EXPERIMENTAL PNEUMONIA : IV. RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMOCOCCUS PNEUMONIA IN MONKEYS.实验性肺炎研究 IV. 预防接种肺炎球菌肺炎在猴子中的结果。
J Exp Med. 1920 Apr 30;31(5):519-53. doi: 10.1084/jem.31.5.519.
4
PRESENT STATUS OF PNEUMOCOCCUS VACCINE.肺炎球菌疫苗的现状
Am J Public Health (N Y). 1919 Aug;9(8):589-92. doi: 10.2105/ajph.9.8.589.
5
STUDIES ON PNEUMOCOCCUS IMMUNITY : II. ACTIVE IMMUNIZATION OF MONKEYS AGAINST PNEUMOCOCCUS TYPES II, III, AND IV PNEUMONIA WITH THE HOMOLOGOUS PNEUMOCOCCUS VACCINE.肺炎球菌免疫研究:Ⅱ. 同源肺炎球菌疫苗对 II、III 和 IV 型肺炎球菌引起的肺炎的猴子主动免疫。
J Exp Med. 1923 Jul 31;38(2):149-61. doi: 10.1084/jem.38.2.149.
6
THE CHARACTER OF THE PNEUMONIC LESIONS PRODUCED BY INTRABRONCHIAL INSUFFLATION OF VIRULENT STREPTOCOCCI.支气管内注入毒力链球菌引起肺炎性损害的特征。
J Exp Med. 1913 Nov 1;18(5):548-55. doi: 10.1084/jem.18.5.548.
7
Efficacy of trivalent seasonal influenza vaccination in reducing mortality and hospitalization in Chinese nursing home older adults.三价季节性流感疫苗接种对降低中国养老院老年人死亡率和住院率的效果。
J Am Med Dir Assoc. 2013 Dec;14(12):889-94. doi: 10.1016/j.jamda.2013.04.004. Epub 2013 May 21.
8
STUDIES ON EXPERIMENTAL PNEUMONIA : IX. PRODUCTION IN MONKEYS OF AN ACUTE RESPIRATORY DISEASE RESEMBLING INFLUENZA BY INOCULATION WITH BACILLUS INFLUENZAE.实验性肺炎研究:IX. 流感杆菌接种引起类似于流感的猴急性呼吸道疾病的产生。
J Exp Med. 1920 Nov 30;32(6):691-717. doi: 10.1084/jem.32.6.691.
9
Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).新型甲型 H1N1 流感大流行期间,对养老院老年人进行双重肺炎球菌和季节性流感疫苗接种可预防死亡和肺炎。
J Am Med Dir Assoc. 2012 Oct;13(8):698-703. doi: 10.1016/j.jamda.2012.05.009. Epub 2012 Jun 20.
10
VARIETIES OF PNEUMOCOCCUS AND THEIR RELATION TO LOBAR PNEUMONIA.肺炎球菌的种类及其与大叶性肺炎的关系。
J Exp Med. 1915 Feb 1;21(2):114-32. doi: 10.1084/jem.21.2.114.

引用本文的文献

1
The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.疫苗对流感后继发性细菌感染的意外影响
Viral Immunol. 2018 Mar;31(2):159-173. doi: 10.1089/vim.2017.0138. Epub 2017 Nov 17.
2
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.以特定荚膜多糖免疫预防肺炎球菌肺炎。
J Exp Med. 1945 Nov 30;82(6):445-65.
3
STUDIES ON EXPERIMENTAL PNEUMONIA : IV. RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMOCOCCUS PNEUMONIA IN MONKEYS.实验性肺炎研究 IV. 预防接种肺炎球菌肺炎在猴子中的结果。
J Exp Med. 1920 Apr 30;31(5):519-53. doi: 10.1084/jem.31.5.519.
4
A puzzling omission in a great medical textbook edited by a pioneer of controlled trials.一本由对照试验先驱编辑的伟大医学教科书中令人费解的遗漏。
J R Soc Med. 2008 Jul;101(7):381-3. doi: 10.1258/jrsm.2008.081009.
5
The pneumococcus and some men who came to Yale: the Dorothy M. Horstmann Lecture.肺炎球菌与一些来到耶鲁的人:多萝西·M·霍斯特曼讲座
Yale J Biol Med. 1993 Jul-Aug;66(4):315-24.

本文引用的文献

1
RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.预防接种肺炎球菌疫苗对 12519 名男性的效果。
J Exp Med. 1918 Jul 1;28(1):19-41. doi: 10.1084/jem.28.1.19.

Wheeler 营的肺炎预防接种结果。

RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMONIA AT CAMP WHEELER.

出版信息

J Exp Med. 1919 May 1;29(5):457-83. doi: 10.1084/jem.29.5.457.

DOI:10.1084/jem.29.5.457
PMID:19868331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2126333/
Abstract
  1. 13,460 men, or about 80 per cent of the entire camp strength, were vaccinated against pneumonia with pneumococcus lipovaccine. 2. The dosage employed in all cases was 1 cc. of the lipovaccine containing approximately 10 billion each of Pneumococcus Types I, II, and III. 3. Both the local and general reactions produced by the vaccine were usually mild. Only 0.7 per cent of those who received the vaccine were sufficiently affected to need hospital care. None of these was seriously ill, and a majority of them returned to duty on the 2nd or 3rd day after admission. 4. Most of the troops inoculated were under observation for 2 or 3 months after vaccination. During this period there were 32 cases of Pneumococcus Type I, II, and III pneumonia among the vaccinated four-fifths of camp, and 42 cases of pneumonia of these types among the unvaccinated one-fifth of camp. If, however, all cases of pneumonia that developed within 1 week after vaccination are excluded from the vaccinated group, there remain only 8 cases of pneumonia produced by fixed types, and these were all secondary to severe attacks of influenza. This exclusion is justified by the fact that protective bodies do not begin to appear in the serum until the 8th day after injection of pneumococcus lipovaccine. 5. There is no evidence whatever that pneumococcus vaccine predisposes the individual even temporarily toward either pneumococcus or streptococcus pneumonia. 6. The weekly incidence rate for pneumonia (all types) among the vaccinated troops was conspicuously lower than that for the unvaccinated troops. 7. The pneumonia incidence rate per 1,000 men during the period of the experiment was twice as high for unvaccinated recruits as for vaccinated recruits, and nearly seven times as high for unvaccinated seasoned men as for vaccinated seasoned men. 8. Influenza causes a marked reduction in resistance to pneumonia even among vaccinated men. Of the 155 cases of pneumonia (all types) developing 1 week or more after vaccination, 133 were secondary to influenza. 9. The death rate for 155 cases of pneumonia (all types) that developed among vaccinated men 1 week or more after vaccination was only 12.2 per cent, whereas the death rate for 327 cases of all types that occurred among unvaccinated troops was 22.3 per cent. The death rate for primary pneumonia among vaccinated troops was 11.9 per cent. Among unvaccinated, it was 31.8 per cent, almost three times as great. On the other hand, the mortality rate in pneumonia secondary to influenza is about the same for the vaccinated and unvaccinated groups. 10. In conclusion, it must be admitted that the results of pneurnococcus vaccination at Camp Wheeler have not been so striking as those obtained at Camp Upton in 1918, largely on account of the influenza epidemic; but, although influenza obscured to some extent the effect of pneumococcus vaccination at Camp Wheeler, the results are sufficiently encouraging to justify its further application in civil as well as in military life.
摘要
  1. 共有 13460 名士兵,约占整个营地人数的 80%,接受了肺炎球菌荚膜多糖疫苗的肺炎预防接种。

  2. 在所有情况下,使用的剂量均为 1 毫升含有约 100 亿个肺炎球菌 I、II 和 III 型的荚膜多糖疫苗。

  3. 疫苗引起的局部和全身反应通常较轻。只有 0.7%的接种者反应严重到需要住院治疗。这些人没有一个病情严重,大多数人在入院后第 2 或第 3 天就返回工作岗位。

  4. 大多数接种疫苗的士兵在接种疫苗后观察了 2 到 3 个月。在此期间,接种疫苗的五分之四的营地中有 32 例肺炎球菌 I、II 和 III 型肺炎,而未接种疫苗的五分之一的营地中有 42 例肺炎。然而,如果将接种疫苗组中接种后 1 周内发生的所有肺炎病例排除在外,仅剩下 8 例由固定类型引起的肺炎,且这些肺炎均继发于严重的流感。这一排除是合理的,因为保护性抗体要在接种肺炎球菌荚膜多糖疫苗后的第 8 天才开始在血清中出现。

  5. 没有任何证据表明肺炎球菌疫苗会使个体暂时易患肺炎球菌或链球菌肺炎。

  6. 接种疫苗的士兵每周肺炎(所有类型)的发病率明显低于未接种疫苗的士兵。

  7. 在实验期间,未接种疫苗的新兵每 1000 名男性中肺炎的发病率是接种疫苗新兵的两倍,而未接种疫苗的有经验士兵是接种疫苗有经验士兵的近七倍。

  8. 流感甚至会使接种疫苗的男性对肺炎的抵抗力明显下降。在接种疫苗后 1 周或更长时间内发生的 155 例肺炎(所有类型)中,有 133 例继发于流感。

  9. 在接种疫苗的 155 例肺炎(所有类型)中,有 12.2%的死亡率仅为 1 周或更长时间后发生的,而在未接种疫苗的 327 例所有类型的肺炎中,死亡率为 22.3%。接种疫苗的新兵原发性肺炎的死亡率为 11.9%。在未接种疫苗的人群中,这一比例为 31.8%,几乎是前者的三倍。另一方面,流感继发肺炎的死亡率在接种疫苗和未接种疫苗的人群中大致相同。

  10. 总之,必须承认,惠勒营的肺炎球菌疫苗接种结果不如 1918 年尤宁营的结果那么显著,这在很大程度上是由于流感流行;但是,尽管流感在一定程度上掩盖了惠勒营肺炎球菌疫苗接种的效果,但结果仍然令人鼓舞,足以证明其在民用和军事生活中的进一步应用是合理的。